TradingView
RocketTickers
Oct 19, 2020 4:34 PM
Mereo BioPharma Announces FDA Clearance to Proceed into a Phase
Long
NASDAQ:MREO
60
Mereo BioPharma Group plc
NASDAQ
Description
⋅
Oct 19, 2020 4:34 PM
MREO: Mereo BioPharma Group plc
2020-10-19 07:00:10
Mereo BioPharma Announces FDA Clearance to Proceed into a Phase 1b/2 study for Etigilimab (Anti-TIGIT)
Beyond Technical Analysis
Comments
VincePrince
⋅
Oct 19, 2020 6:26 PM
These pharmas are risky but profitable
More